Cargando…

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation

Detalles Bibliográficos
Autores principales:	Yetkin, E., Yalta, K., Waltenberger, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341998/ https://www.ncbi.nlm.nih.gov/pubmed/32643072 http://dx.doi.org/10.1007/s12471-020-01464-4

Ejemplares similares

Hydroxychloroquine and QT prolongation: reassuring data in approved indications
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

HCQ induced QT prolongation- Primum non nocere
por: Mahendran, A.J., et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Pheochromocytoma and Takotsubo Syndrome: An Ominous Duo
por: Yalta, Kenan, et al.
Publicado: (2022)

Recurrent Cardiac Myxoma: A Puzzle to be Solved
por: Yalta, Kenan, et al.
Publicado: (2023)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Discordant results about QT prolongation in patients with Turner syndrome
por: Keskin, Berhan, et al.
Publicado: (2018)

Does pulmonary vein isolation prolong QT-interval?— Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

Systemic Inflammation in the Setting of Cardiac Myxomas: an Overview of Clinical and Practical Considerations
por: Yalta, Kenan, et al.
Publicado: (2021)

Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
por: Yalta, Kenan, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications
por: Yalta, Kenan, et al.
Publicado: (2023)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval
por: Yiginer, Omer, et al.
Publicado: (2015)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation
por: Rezazadeh, Amir, et al.
Publicado: (2021)

Corrected QT interval prolongation after ganglionated plexus ablation: myth or reality?—Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era
por: Singla, Karan, et al.
Publicado: (2022)

Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
por: Yalta, K, et al.
Publicado: (2012)

Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation. Response
por: Bonanad, Clara, et al.
Publicado: (2021)

A mathematical model to understand the mechanisms of action of class 1 antiarrhythmic drugs
por: Jain, Dinesh K., et al.
Publicado: (2010)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

QT interval prolongation in geriatric patients treated for SARS-COV-2 infection: OCTA-COVID study()()
por: Garmendia-Prieto, Blanca, et al.
Publicado: (2021)

Takotsubo syndrome in the absence of an overt stressor: A glimpse into its mechanistic and clinical aspects
por: Yalta, Kenan, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i8c3d0q9s4eipbilfap5ehcp2k